Assessment of transient left ventricular dilation ratio via 2-day dipyridamole Tc-99m sestamibi nongated myocardial perfusion imaging

被引:29
作者
Kakhki, Vahid Reza Dabbagh [1 ]
Sadeghi, Ramin [1 ]
Zakavi, Seyed Rasoul [1 ]
机构
[1] Mashhad Univ Med Sci, Imam Reza Hosp, Dept Nucl Med, Mashhad, Iran
关键词
transient ischemic dilation; myocardial perfusion single photon emission computed tomography; dipyridamole; ischemia;
D O I
10.1016/j.nuclcard.2007.03.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. The definition of an abnormal transient ischemic dilation (TID) ratio may be different according to stress type, type of isotope, and imaging protocols. The aim of this study was to derive the normal threshold and assessment of the TID ratio via 2-day dipyridamole stress/rest technetium 99m sestamibi myocardial perfusion single photon emission computed tomography (NIPS). Methods and Results. We performed 2-day dipyridamole stress/rest Tc-99m sestamibi MPS in 665 patients. The TID ratio was calculated automatically with the Emory Cardiac Toolbox. The upper limit of normal (1.19) for the TID ratio was derived from 131 patients with a low (<5%) likelihood of coronary artery disease as mean + 2 SDs. Patients with complete or partial reversible defects or multivessel-type or left anterior descending artery (LAD) territory perfusion abnormalities had higher TID ratios than the other patients. These patients had a higher frequency of an abnormal TID ratio (>1.19) as well. Binary logistic regression analysis showed that ischemia and LAD territory perfusion abnormality were independent predictors of an abnormal TID ratio. Conclusion. The threshold for an abnormal TID ratio via 2-day post-dipyridamole stress/rest Tc-99m sestamibi MPS was greater than 1.19. By use of this protocol, TID is not uncommon and it is related to a greater amount of ischemic burden as well as multivessel-type or LAD territory perfusion abnormality.
引用
收藏
页码:529 / 536
页数:8
相关论文
共 32 条
[1]  
Abidov A, 2004, J NUCL MED, V45, P1999
[2]   Transient ischemic dilation associated with poststress myocardial stunning of the left ventricle in vasodilator stress myocardial perfusion SPECT: True marker of severe ischemia? [J].
Abidov, A ;
Berman, DS .
JOURNAL OF NUCLEAR CARDIOLOGY, 2005, 12 (03) :258-260
[3]  
Beretta M, 2001, J NUCL CARDIOL, V8, pS77
[4]   MYOCARDIAL STUNNING IN MAN [J].
BOLLI, R .
CIRCULATION, 1992, 86 (06) :1671-1691
[5]   Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart - A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association [J].
Cerqueira, MD ;
Weissman, NJ ;
Dilsizian, V ;
Jacobs, AK ;
Kaul, S ;
Laskey, WK ;
Pennell, DJ ;
Rumberger, JA ;
Ryan, T ;
Verani, MS .
CIRCULATION, 2002, 105 (04) :539-542
[6]   Transient left ventricular dilatation in the absence of epicardial disease on angiography [J].
Choong, KKL ;
Russell, PA .
CLINICAL NUCLEAR MEDICINE, 2004, 29 (06) :348-351
[7]   Myocardial stunning induced and detected by adenosine stress perfusion imaging [J].
Dakik, HA ;
Alam, S .
JOURNAL OF NUCLEAR CARDIOLOGY, 2001, 8 (06) :711-712
[8]  
de Albuquerque Fonseca L, 2001, WORLD J NUCL MED, V87, P1193
[9]   BAYESIAN PROBABILITY ANALYSIS - A PROSPECTIVE DEMONSTRATION OF ITS CLINICAL UTILITY IN DIAGNOSING CORONARY-DISEASE [J].
DETRANO, R ;
YIANNIKAS, J ;
SALCEDO, EE ;
RINCON, G ;
GO, RT ;
WILLIAMS, G ;
LEATHERMAN, J .
CIRCULATION, 1984, 69 (03) :541-547
[10]   APPLICATION OF CONDITIONAL-PROBABILITY ANALYSIS TO THE CLINICAL-DIAGNOSIS OF CORONARY-ARTERY DISEASE [J].
DIAMOND, GA ;
FORRESTER, JS ;
HIRSCH, M ;
STANILOFF, HM ;
VAS, R ;
BERMAN, DS ;
SWAN, HJC .
JOURNAL OF CLINICAL INVESTIGATION, 1980, 65 (05) :1210-1221